載入...
Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status and pre-existing antigen-specific immunity as possible biomarkers for patient prognosis
Considering that the prognosis of patients with advanced biliary tract cancer (BTC) remains very poor, with a median survival of less than 1 year, new therapeutic approaches need to be developed. In the present study, a phase II clinical trial of personalized peptide vaccination (PPV) was conducted...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3438646/ https://ncbi.nlm.nih.gov/pubmed/22969912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2011.424 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|